The Challenges and Opportunities of Technology Transfer in the Cell and Gene Therapy Industry: An Interview with Roberto Formisano

Current developments in technology transfer to a Contract Development and Manufacturing Organization (CDMO)

Roberto Formisano, Process Transfer Senior Manager at AGC Biologics, shares his insights on the challenges associated with technology transfer during a video interview. He discusses the nuances of technology transfer from development to GMP manufacturing and from a customer to a contract development and manufacturing organization (CDMO).

One of the key challenges Roberto highlights is the critical timelines that are essential in the process of technology transfer. Balancing the number of batches that need to be manufactured to ensure sufficient quality data while adhering to these timelines poses a significant challenge in the industry.

Roberto also predicts technology and manufacturing trends that are expected to shape the cell and gene therapy industry by 2024. His insights provide valuable perspectives on the future direction of the industry.

During an interview at Terrapin’s Advanced Therapies conference in London on 19 March, Roberto had a conversation with EPR editor Caroline Peachey. The interview sheds light on the complexities of technology transfer and offers valuable insights into the industry’s challenges and opportunities.

Leave a Reply